{"title":"[给予母亲药物的新生儿结局]。","authors":"M L Talafré, G Barrier","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Most drugs given to pregnant women at the end of pregnancy and during delivery cross the placenta and can therefore be the cause of disorders in the neonate. A study of neonatal pharmacokinetics of drugs administered to women during delivery, correlated with a study of fetal physiology and the neurosensorial behavior of the neonate should allow us to better understand certain disorders of neonatal adaptations to extra-uterine life.</p>","PeriodicalId":8081,"journal":{"name":"Annales de l'anesthesiologie francaise","volume":"22 2","pages":"119-26"},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The neonatal outcome of drugs administered to the mother].\",\"authors\":\"M L Talafré, G Barrier\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Most drugs given to pregnant women at the end of pregnancy and during delivery cross the placenta and can therefore be the cause of disorders in the neonate. A study of neonatal pharmacokinetics of drugs administered to women during delivery, correlated with a study of fetal physiology and the neurosensorial behavior of the neonate should allow us to better understand certain disorders of neonatal adaptations to extra-uterine life.</p>\",\"PeriodicalId\":8081,\"journal\":{\"name\":\"Annales de l'anesthesiologie francaise\",\"volume\":\"22 2\",\"pages\":\"119-26\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1981-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales de l'anesthesiologie francaise\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales de l'anesthesiologie francaise","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[The neonatal outcome of drugs administered to the mother].
Most drugs given to pregnant women at the end of pregnancy and during delivery cross the placenta and can therefore be the cause of disorders in the neonate. A study of neonatal pharmacokinetics of drugs administered to women during delivery, correlated with a study of fetal physiology and the neurosensorial behavior of the neonate should allow us to better understand certain disorders of neonatal adaptations to extra-uterine life.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
